DE2552289C2 - Chinoxalin-1,4-dioxydderivate sowie diese enthaltende Arzneimittel und Beifuttermittel und Verfahren zur Herstellung derselben - Google Patents
Chinoxalin-1,4-dioxydderivate sowie diese enthaltende Arzneimittel und Beifuttermittel und Verfahren zur Herstellung derselbenInfo
- Publication number
- DE2552289C2 DE2552289C2 DE2552289A DE2552289A DE2552289C2 DE 2552289 C2 DE2552289 C2 DE 2552289C2 DE 2552289 A DE2552289 A DE 2552289A DE 2552289 A DE2552289 A DE 2552289A DE 2552289 C2 DE2552289 C2 DE 2552289C2
- Authority
- DE
- Germany
- Prior art keywords
- quinoxaline
- dioxide
- radical
- formylquinoxaline
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CKIHZSGJPSDCNC-UHFFFAOYSA-N Quindoxin Chemical class C1=CC=C2N([O-])C=C[N+](=O)C2=C1 CKIHZSGJPSDCNC-UHFFFAOYSA-N 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 9
- 239000003814 drug Substances 0.000 title description 4
- 238000004519 manufacturing process Methods 0.000 title description 2
- -1 methoxy radicals Chemical class 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 6
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- DUUPDCPVCHSTFF-UHFFFAOYSA-N nonane Chemical group [CH2]CCCCCCCC DUUPDCPVCHSTFF-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 description 11
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- JZJFIUXMPBVEFS-UHFFFAOYSA-N 1-oxido-4-oxoquinoxalin-4-ium-2-carbaldehyde Chemical compound C1=CC=C2N([O-])C(C=O)=C[N+](=O)C2=C1 JZJFIUXMPBVEFS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001241 acetals Chemical class 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000007900 aqueous suspension Substances 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 235000021051 daily weight gain Nutrition 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 241000108056 Monas Species 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241001467018 Typhis Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 description 1
- DVIHKVWYFXLBEM-UHFFFAOYSA-N 2-hydroxybenzoyl chloride Chemical compound OC1=CC=CC=C1C(Cl)=O DVIHKVWYFXLBEM-UHFFFAOYSA-N 0.000 description 1
- BUHYMJLFRZAFBF-UHFFFAOYSA-N 3,4,5-trimethoxybenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC(OC)=C1OC BUHYMJLFRZAFBF-UHFFFAOYSA-N 0.000 description 1
- ZMZGIVVRBMFZSG-UHFFFAOYSA-N 4-hydroxybenzohydrazide Chemical compound NNC(=O)C1=CC=C(O)C=C1 ZMZGIVVRBMFZSG-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- IODMEDPPCXSFLD-UHFFFAOYSA-N 5-nitrofuran-2-carboxylic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)O1 IODMEDPPCXSFLD-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 241001400590 Richia Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960000427 carbadox Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- IPIVAXLHTVNRBS-UHFFFAOYSA-N decanoyl chloride Chemical compound CCCCCCCCCC(Cl)=O IPIVAXLHTVNRBS-UHFFFAOYSA-N 0.000 description 1
- YTQHSQQSLTYMSL-UHFFFAOYSA-N dodecanohydrazide Chemical compound CCCCCCCCCCCC(=O)NN YTQHSQQSLTYMSL-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BPMVRAQIQQEBLN-OBPBNMOMSA-N methyl n-[(e)-(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methyl]iminocarbamate Chemical compound C1=CC=C2N(O)C(=C/N=NC(=O)OC)/C=[N+]([O-])C2=C1 BPMVRAQIQQEBLN-OBPBNMOMSA-N 0.000 description 1
- WFJRIDQGVSJLLH-UHFFFAOYSA-N methyl n-aminocarbamate Chemical compound COC(=O)NN WFJRIDQGVSJLLH-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000576 supplementary effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUEE2278A HU169299B (h) | 1974-11-21 | 1974-11-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2552289A1 DE2552289A1 (de) | 1976-05-26 |
| DE2552289C2 true DE2552289C2 (de) | 1986-05-07 |
Family
ID=10995579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2552289A Expired DE2552289C2 (de) | 1974-11-21 | 1975-11-21 | Chinoxalin-1,4-dioxydderivate sowie diese enthaltende Arzneimittel und Beifuttermittel und Verfahren zur Herstellung derselben |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS6049634B2 (h) |
| AT (1) | AT344702B (h) |
| BE (1) | BE835763A (h) |
| CH (1) | CH623042A5 (h) |
| CS (1) | CS232703B2 (h) |
| DD (1) | DD123604A5 (h) |
| DE (1) | DE2552289C2 (h) |
| DK (1) | DK138389B (h) |
| FI (1) | FI61887C (h) |
| FR (1) | FR2291756A1 (h) |
| GB (1) | GB1479239A (h) |
| HU (1) | HU169299B (h) |
| IL (1) | IL48463A (h) |
| IN (1) | IN140110B (h) |
| NL (1) | NL7513446A (h) |
| PL (1) | PL96412B1 (h) |
| SE (2) | SE423095B (h) |
| SU (1) | SU612628A3 (h) |
| YU (1) | YU39953B (h) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1058490B (it) * | 1976-03-18 | 1982-04-10 | Ind Chimica Prodotti Francis S | Procedimento di fabbricazione di alchil 3 2 chinossalinilmetilen carbazato 1.4 diossido |
| HU184772B (en) * | 1980-05-23 | 1984-10-29 | Egyt Gyogyszervegyeszeti Gyar | Process for preparing quinoxaline-1,4-dioxide derivatives |
| HU184825B (en) * | 1980-09-12 | 1984-10-29 | Egyt Gyogyszervegyeszeti Gyar | Process for preparing new 2-hydroxy-methyl-quinoxaline-1,4-dioxide derivatives |
| JPH03500769A (ja) * | 1987-07-31 | 1991-02-21 | ジ・アップジョン・カンパニー | 駆虫薬アシルヒドラゾン、使用方法および組成物 |
| US5049561A (en) * | 1987-07-31 | 1991-09-17 | The Upjohn Company | Anthelmintic acylhydrazones, method of use and compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1469485A (fr) * | 1964-09-16 | 1967-02-17 | Pfizer & Co C | Procédé pour la préparation d'une nouvelle série de bases de schiff |
| US3371090A (en) * | 1964-09-16 | 1968-02-27 | Pfizer & Co C | Novel antibacterial agents |
-
1974
- 1974-11-21 HU HUEE2278A patent/HU169299B/hu not_active IP Right Cessation
-
1975
- 1975-11-11 IL IL48463A patent/IL48463A/xx unknown
- 1975-11-14 IN IN2177/CAL/75A patent/IN140110B/en unknown
- 1975-11-14 SE SE7512857A patent/SE423095B/xx unknown
- 1975-11-17 FI FI753225A patent/FI61887C/fi not_active IP Right Cessation
- 1975-11-17 CH CH1484575A patent/CH623042A5/de not_active IP Right Cessation
- 1975-11-17 AT AT872275A patent/AT344702B/de not_active IP Right Cessation
- 1975-11-18 FR FR7535184A patent/FR2291756A1/fr active Granted
- 1975-11-18 NL NL7513446A patent/NL7513446A/xx not_active Application Discontinuation
- 1975-11-18 GB GB47418/75A patent/GB1479239A/en not_active Expired
- 1975-11-18 DK DK518275AA patent/DK138389B/da unknown
- 1975-11-19 CS CS757830A patent/CS232703B2/cs unknown
- 1975-11-19 SU SU752189810A patent/SU612628A3/ru active
- 1975-11-20 DD DD189588A patent/DD123604A5/xx unknown
- 1975-11-20 BE BE162030A patent/BE835763A/xx not_active IP Right Cessation
- 1975-11-20 PL PL1975184870A patent/PL96412B1/pl unknown
- 1975-11-20 YU YU2942/75A patent/YU39953B/xx unknown
- 1975-11-21 JP JP50139369A patent/JPS6049634B2/ja not_active Expired
- 1975-11-21 DE DE2552289A patent/DE2552289C2/de not_active Expired
-
1979
- 1979-01-16 SE SE7900389A patent/SE423387B/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT344702B (de) | 1977-12-15 |
| PL96412B1 (pl) | 1977-12-31 |
| SE423387B (sv) | 1982-05-03 |
| ATA872275A (de) | 1977-12-15 |
| DD123604A5 (h) | 1977-01-05 |
| HU169299B (h) | 1976-11-28 |
| JPS6049634B2 (ja) | 1985-11-02 |
| YU39953B (en) | 1985-06-30 |
| IN140110B (h) | 1976-09-18 |
| GB1479239A (en) | 1977-07-06 |
| CH623042A5 (en) | 1981-05-15 |
| FR2291756B1 (h) | 1978-11-10 |
| FI753225A7 (h) | 1976-05-22 |
| DE2552289A1 (de) | 1976-05-26 |
| FI61887B (fi) | 1982-06-30 |
| DK138389B (da) | 1978-08-28 |
| NL7513446A (nl) | 1976-05-25 |
| YU294275A (en) | 1982-06-30 |
| DK518275A (h) | 1976-05-22 |
| FI61887C (fi) | 1982-10-11 |
| SE7900389L (sv) | 1979-01-16 |
| IL48463A0 (en) | 1976-01-30 |
| SE7512857L (sv) | 1976-05-24 |
| SU612628A3 (ru) | 1978-06-25 |
| BE835763A (fr) | 1976-03-16 |
| FR2291756A1 (fr) | 1976-06-18 |
| SE423095B (sv) | 1982-04-13 |
| IL48463A (en) | 1978-10-31 |
| JPS5175082A (en) | 1976-06-29 |
| DK138389C (h) | 1979-02-05 |
| CS232703B2 (en) | 1985-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH648037A5 (de) | Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit. | |
| DE1470439B1 (de) | Chinolinderivate und Verfahren zu ihrer Herstellung | |
| DE1927473C3 (de) | Verfahren zur Herstellung von Phenazin-N,N-dioxiden | |
| DE2552289C2 (de) | Chinoxalin-1,4-dioxydderivate sowie diese enthaltende Arzneimittel und Beifuttermittel und Verfahren zur Herstellung derselben | |
| CH507292A (de) | Verfahren zur Herstellung von Derivaten der 7-Amino-cephalosporansäure | |
| DE3035259C2 (de) | Cephalosporinverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten | |
| DE2003144A1 (de) | Verfahren zur Herstellung von 5-Imino-1,2,4-triazin-Derivaten | |
| DE2934355A1 (de) | (alpha)-acyl(thioacyl)amino-lactame, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel, futterzusatzstoffe und konservierungsmittel | |
| EP0012725B1 (de) | Chinoxalin-Di-N-oxid-Derivate, Verfahren zu ihrer Herstellung, Mittel diese enthaltend und ihre Verwendung | |
| DE2147103C3 (de) | Imidazo eckige Klammer auf 4,5-b eckige Klammer zu pyridine | |
| CH648025A5 (de) | Chinoxalin-1,4-dioxyd-derivate. | |
| DE3024304C2 (h) | ||
| AT364836B (de) | Verfahren zur herstellung von neuen o-substituierten derivaten des (+)-cyanidan-3-ols und deren salzen | |
| DE1445438C (h) | ||
| AT326101B (de) | Verfahren zur herstellung von neuen substituierten formylazapentadiennitrilen sowie von deren säureadditionssalzen | |
| AT266116B (de) | Verfahren zur Herstellung von neuen aliphatischen α-(3-Indolyl)-carbonsäuren und ihren Salzen | |
| AT230369B (de) | Verfahren zur Herstellung von neuen Alkoxyalkyl-hydrazonen | |
| DE1620056C (de) | Kalium 6 eckige Klammer auf 3 methoxy 5 phenylisothiazol 4 carboxamido eckige Klammer zu pem cillanat und Verfahren zu seiner Her stellung | |
| DE1470283C (de) | l-Methyl-5-sulfanilamido-pyridazon-(6)-derivate | |
| DE2220830C3 (de) | Verfahren zum selektiven Oxydieren von Carbalkoxy-1,3-lndandion-Salzen | |
| AT220149B (de) | Verfahren zur Herstellung von Aryloxymethyl-2-oxazolidinonen | |
| DE1284426B (de) | 4-(5'-Nitro-2'-furfuryliden-amino)-1, 2, 4-triazolone-(5) und Verfahren zu ihrer Herstellung | |
| AT271723B (de) | Verfahren zur Herstellung von neuen Derivaten der 6-Aminopenicillansäure | |
| CH396003A (de) | Verfahren zur Herstellung von Penicillinderivaten | |
| AT229316B (de) | Verfahren zur Herstellung von neuen 3- und 3,5-substituierten 2-Aminopyrazinderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |